Pick Your Community: | Hopkins | Muhlenberg | Daviess | Christian | Fayette | Henderson | Lakes | McCracken | Warren | Webster

FDA Approves Ragwitek for Short Ragweed Pollen Allergies

spring-allergiesKENTUCKY (4/17/14) — The U.S. Food and Drug Administration today approved Ragwitek, the first allergen extract administered under the tongue (sublingually) to treat short ragweed pollen induced allergic rhinitis (hay fever), with or without conjunctivitis (eye inflammation), in adults 18 years through 65 years of age.

Ragwitek contains an extract from short ragweed (Ambrosia artemisiifolia) pollen. It is a tablet that is taken once daily by placing it sublingually, where it rapidly dissolves. Treatment with Ragwitek is started 12 weeks before the start of ragweed pollen season and continued throughout the season. The first dose is taken in a health care professional’s office where the patient is to be observed for at least 30 minutes for potential adverse reactions. After the first dose, patients can take Ragwitek at home.

“The approval of Ragwitek offers millions of adults living with ragweed pollen allergies in the United States an alternative to allergy shots to help manage their disease,” said Karen Midthun, M.D., director of the FDA’s Center for Biologics Evaluation and Research.

Individuals with allergic rhinitis with or without conjunctivitis may experience a runny nose, repetitive sneezing, nasal itching, nasal congestion, and itchy and watery eyes. Short ragweed pollen is one of the most common seasonal allergens and is prevalent during the late summer and early fall months in most of the United States. Short ragweed pollen induced allergies are generally managed by avoiding the allergen, medications to relieve symptoms, or with allergy shots.

The safety and effectiveness of Ragwitek was evaluated in studies conducted in the United States and internationally. Safety was assessed in approximately 1,700 adults. The most commonly reported adverse reactions by patients treated with Ragwitek were itching in the mouth and ears and throat irritation. Of the 1,700 adults, about 760 were evaluated to determine effectiveness. Some patients received Ragwitek; others received an inactive substitute (placebo). The patients reported their symptoms and additional medications needed to get through the allergy season. During treatment for one ragweed pollen season, patients who received Ragwitek experienced approximately a 26 percent reduction in symptoms and the need for medications compared to those who received a placebo.

The Prescribing Information includes a boxed warning to inform that severe allergic reactions, some of which can be life threatening, can occur. Ragwitek also has a Medication Guide for distribution to the patient.

Ragwitek is manufactured for Merck, Sharp & Dohme Corp., (a subsidiary of Merck and Co., Inc., Whitehouse Station, N.J.) by Catalent Pharma Solutions Limited, United Kingdom. For more information: Allergenics.

Read more on SurfKY about allergies:

Spring Allergies May Come From Everyday Things

Scoping It Out: Spring is Here, Do You Have the Fever?

SurfKY News
Information provided by FDA

© Copyright 2014 SurfKY News Group, Inc. All rights reserved. This material may not be published, broadcast, or rewritten without permission. SurfKY News encourages you to share this story by using one of the social media links below.

Most Read This Week (Site-Wide)

July 30, 2014 4411

Three Arrested in Muhlenberg as Part of…

in Top Stories by GPD Officer Wes Miller
July 30, 2014 3658

UPDATE: Waide Responds to Allegations of…

in Top Stories by Rita Dukes Smith, SurfKY News Director
July 28, 2014 3647

Madisonville Woman Arrested for Being a…

in Top Stories by Madisonville Police Department
July 28, 2014 3155

Madisonville Man Arrested for Endangering…

in Top Stories by Madisonville Police Department
July 30, 2014 2743

UPDATE: Muhlenberg Man, Woman Arrested in…

in Top Stories by Sheriff Curtis McGehee

Most Read Stories from Hopkins County

July 28, 2014 3647

Madisonville Woman Arrested for Being a…

in Top Stories by Madisonville Police Department
July 28, 2014 3155

Madisonville Man Arrested for Endangering…

in Top Stories by Madisonville Police Department
July 28, 2014 2675

Disagreement Over Killing Snake in House…

in Top Stories by Madisonville Police Department
July 30, 2014 2120

Murder Charges Filed in Death of Hanson…

in Top Stories by Det. Jonathon Barnes
July 31, 2014 1976

Nortonville Man Accused of Stashing Drugs…

in Top Stories by Madisonville Police Department

Most Read Stories from Owensboro

July 28, 2014 1528

Zuberer Takes Over at Quarterback for…

in News by Steve LeMaster
July 28, 2014 1385

Dont Miss Out on a Howl of a Good Time

in News by Brittni Bunn
July 28, 2014 1252

Instant Admissions Day is Aug. 1, 2014

in News by Bernie Hale
July 29, 2014 1077

Happenings and Meetings - Daviess County

in News by Owensboro-Daviess County Convention & Visitors Bureau
July 28, 2014 504

Prosecutors Mull Over Whether to Charge…

in Top Stories by Dennis Beard, SurfKY News

Most Read Stories from Muhlenberg County

July 30, 2014 4411

Three Arrested in Muhlenberg as Part of…

in Top Stories by GPD Officer Wes Miller
July 30, 2014 2743

UPDATE: Muhlenberg Man, Woman Arrested in…

in Top Stories by Sheriff Curtis McGehee
July 28, 2014 1768

Foot Pursuit Ends with Arrest

in Top Stories by Christopher Rogers
July 29, 2014 1726

Muhlenberg District Court Fines Handed…

in Top Stories by Charles W. Riley II, SurfKY News
July 28, 2014 1687

Boys of Broad to Launch Video at Cinema 4

in Top Stories by Paul McRee, SurfKY News

SurfKY News Group, Inc. Central Office & Printing Division
1125 Nebo Rd.  •  Madisonville, KY 42431  •  270.452.2249 (fax)
Main Number: 270.452.2727 (phone)  •  Printing Division Direct Line: 270.821.8600 (phone)

SurfKY Owensboro News Bureau
920 Frederica St. / Suite 210  •  Owensboro, KY 42301  •  270.683-8060 (phone)


Contact a member of our staff: www.surfky.com/contact
Copyright © 2014 SurfKY News Group, Inc.  •  Terms of Use  •  Site Map

social 06social 21social 22social 04social 03